Learn how NEJM.org uses cookies at the Cookie Information page.

Perspective

The Groningen Protocol — Euthanasia in Severely Ill Newborns

Eduard Verhagen, M.D., J.D., and Pieter J.J. Sauer, M.D., Ph.D.

N Engl J Med 2005; 352:959-962March 10, 2005DOI: 10.1056/NEJMp058026

Article

Of the 200,000 children born in the Netherlands every year, about 1000 die during the first year of life. For approximately 600 of these infants, death is preceded by a medical decision regarding the end of life. Discussions about the initiation and continuation of treatment in newborns with serious medical conditions are one of the most difficult aspects of pediatric practice. Although technological developments have provided tools for dealing with many consequences of congenital anomalies and premature birth, decisions regarding when to start and when to withhold treatment in individual cases remain very difficult to make. Even more difficult are the decisions regarding newborns who have serious disorders or deformities associated with suffering that cannot be alleviated and for whom there is no hope of improvement.

Suffering is a subjective feeling that cannot be measured objectively, whether in adults or in infants. But we accept that adults can indicate when their suffering is unbearable. Infants cannot express their feelings through speech, but they do so through different types of crying, movements, and reactions to feeding. Pain scales for newborns, based on changes in vital signs (blood pressure, heart rate, and breathing pattern) and observed behavior, may be used to determine the degree of discomfort and pain. Experienced caregivers and parents are able to evaluate the degree of suffering in a newborn, as well as the degree of relief afforded by medication or other measures. In the Netherlands, euthanasia for competent persons older than 16 years of age has been legally accepted since 1985. The question under consideration now is whether deliberate life-ending procedures are also acceptable for newborns and infants, despite the fact that these patients cannot express their own will. Or must infants with disorders associated with severe and sustained suffering be kept alive when their suffering cannot be adequately reduced?

In the Netherlands, as in all other countries, ending someone's life, except in extreme conditions, is considered murder. A life of suffering that cannot be alleviated by any means might be considered one of these extreme conditions. Legal control over euthanasia in newborns is based on physicians' own reports, followed by assessment by criminal prosecutors. To provide all the information needed for assessment and to prevent interrogations by police officers, we developed a protocol, known as the Groningen protocol, for cases in which a decision is made to actively end the life of a newborn. During the past few months, the international press has been full of blood-chilling accounts and misunderstandings concerning this protocol.

Infants and newborns for whom such end-of-life decisions might be made can be divided into three categories.1 First, there are infants with no chance of survival. This group consists of infants who will die soon after birth, despite optimal care with the most current methods available locally. These infants have severe underlying disease, such as lung and kidney hypoplasia.

Infants in the second group have a very poor prognosis and are dependent on intensive care. These patients may survive after a period of intensive treatment, but expectations regarding their future condition are very grim. They are infants with severe brain abnormalities or extensive organ damage caused by extreme hypoxemia. When these infants can survive beyond the period of intensive care, they have an extremely poor prognosis and a poor quality of life.

Finally, there are infants with a hopeless prognosis who experience what parents and medical experts deem to be unbearable suffering. Although it is difficult to define in the abstract, this group includes patients who are not dependent on intensive medical treatment but for whom a very poor quality of life, associated with sustained suffering, is predicted. For example, a child with the most serious form of spina bifida will have an extremely poor quality of life, even after many operations. This group also includes infants who have survived thanks to intensive care but for whom it becomes clear after intensive treatment has been completed that the quality of life will be very poor and for whom there is no hope of improvement.

Deciding not to initiate or to withdraw life-prolonging treatment in newborns with no chance of survival is considered good practice for physicians in Europe and is acceptable for physicians in the United States. Most such infants die immediately after treatment has been discontinued.

Neonatologists in the Netherlands and the majority of neonatologists in Europe are convinced that intensive care treatment is not a goal in itself. Its aim is not only survival of the infant, but also an acceptable quality of life. Forgoing or not initiating life-sustaining treatment in children in the second group is acceptable to these neonatologists if both the medical team and the parents are convinced that treatment is not in the best interest of the child because the outlook is extremely poor.

Confronted with a patient in the third category, it is vital for the medical team to have as accurate a prognosis as possible and to discuss it with the parents. All possible measures must be taken to alleviate severe pain and discomfort. There are, however, circumstances in which, despite all measures taken, suffering cannot be relieved and no improvement can be expected. When both the parents and the physicians are convinced that there is an extremely poor prognosis, they may concur that death would be more humane than continued life. Under similar conditions, a person in the Netherlands who is older than 16 years of age can ask for euthanasia. Newborns, however, cannot ask for euthanasia, and such a request by parents, acting as the representatives of their child, is invalid under Dutch law. Does this mean that euthanasia in a newborn is always prohibited? We are convinced that life-ending measures can be acceptable in these cases under very strict conditions: the parents must agree fully, on the basis of a thorough explanation of the condition and prognosis; a team of physicians, including at least one who is not directly involved in the care of the patient, must agree; and the condition and prognosis must be very well defined. After the decision has been made and the child has died, an outside legal body should determine whether the decision was justified and all necessary procedures have been followed.

A national survey of neonatologists in the Netherlands has shown that each year there are 15 to 20 cases of euthanasia in newborn infants who would be categorized in the third group.2 According to Dutch law, it is a doctor's duty to file a death certificate when a patient has died from natural causes. If a death is due to euthanasia, it cannot be certified as “natural.” The doctor must inform the coroner, who inspects the body and, in turn, informs the district attorney, whose office reviews each case in light of the applicable laws or jurisprudence. The district attorney presents the case, together with his or her own opinion, to the College of Attorneys General, whose four members manage the national public prosecution department and provisionally decide whether or not to prosecute. The final decision is made by the minister of justice.

Two court cases, decided in the mid-1990s, regarding euthanasia in infants in the Netherlands provide some guidance for both judges and physicians. In the first case, a physician ended the life of a newborn who had an extreme form of spina bifida. In the second case, a physician ended the life of a newborn who had trisomy 13. Both cases involved a very limited life expectancy and extreme suffering that could not be alleviated. In their verdicts, the courts approved the procedures as meeting the requirements for good medical practice. Although these rulings have given some guidance, many organizations have repeatedly pleaded for clearer guidelines, arguing that a committee with multidisciplinary (medical, legal, and ethical) expertise would be more capable than judges of assessing such cases. Physicians would be expected to be much more willing to report procedures to such a committee than they are to report to a district attorney. The Dutch government, however, has neither created a committee nor offered other guidance, despite having promised repeatedly, since 1997, to do so.

Twenty-two cases of euthanasia in newborns have been reported to district attorneys' offices in the Netherlands during the past seven years. Recently, we were allowed to review these cases.3 They all involved infants with very severe forms of spina bifida. In most cases (17 of the 22), a multidisciplinary spina bifida team was consulted. In the remaining five cases, at least two other independent medical experts were consulted. The physicians based their decisions on the presence of severe suffering without hope of improvement (see Table 1Table 1Considerations Used to Support the Decision to End the Life of a Newborn in 22 Cases.). The decisions were always made in collaboration with, and were fully approved by, both parents. The prosecutor used four criteria to assess each case: the presence of hopeless and unbearable suffering and a very poor quality of life, parental consent, consultation with an independent physician and his or her agreement with the treating physicians, and the carrying out of the procedure in accordance with the accepted medical standard. The conclusion in all 22 cases was that the requirements of careful practice were fulfilled. None of the physicians were prosecuted.

Given that the national survey indicated that such procedures are performed in 15 to 20 newborns per year, the fact that an average of three cases were reported annually suggests that most cases are simply not being reported. We believe that all cases must be reported if the country is to prevent uncontrolled and unjustified euthanasia and if we are to discuss the issue publicly and thus further develop norms regarding euthanasia in newborns. With that aim, we developed a protocol in 2002, in close collaboration with a district attorney. The protocol contains general guidelines and specific requirements related to the decision about euthanasia and its implementation. Five medical requirements must be fulfilled; other criteria are supportive, designed to clarify the decision and facilitate assessment (see Table 2Table 2The Groningen Protocol for Euthanasia in Newborns.). Following the protocol does not guarantee that the physician will not be prosecuted. Since implementing this protocol, our group has reported four cases in which we performed a deliberate life-ending procedure in a newborn. None have resulted in prosecution.

Dilemmas regarding end-of-life decisions for newborns with a very poor quality of life and presumably unbearable suffering and no hope of improvement are shared by physicians throughout the world. In the Netherlands, obligatory reporting with the aid of a protocol and subsequent assessment of euthanasia in newborns help us to clarify the decision-making process. This approach suits our legal and social culture, but it is unclear to what extent it would be transferable to other countries.

Source Information

Dr. Verhagen is the clinical director and Dr. Sauer the chairman of the pediatrics department at University Medical Center Groningen, Groningen, the Netherlands. Dr. Verhagen is also an attorney.

References

References

  1. 1

    Sauer PJ. Ethical dilemmas in neonatology: recommendations of the Ethics Working Group of the CESP (Confederation of European Specialists in Paediatrics). Eur J Pediatr 2001;160:364-368
    CrossRef | Web of Science | Medline

  2. 2

    van der Heide A, van der Maas PJ, van der Wal G, et al. Medical end-of-life decisions made for neonates and infants in the Netherlands. Lancet 1997;350:251-255
    CrossRef | Web of Science | Medline

  3. 3

    Verhagen AAE, Sol JJ, Brouwer OF, Sauer PJ. Actieve levensbeeindiging bij pasgeborenen in Nederland, Een analyse van alle meldingen van 1997-2004. Ned Tijdschr Geneeskd 2005;149:183-188
    Medline

Citing Articles (100)

Citing Articles

  1. 1

    Jacob J.E. Koopman, Theo A. Boer. (2016) Turning Points in the Conception and Regulation of Physician-Assisted Dying in the Netherlands. The American Journal of Medicine 129:8, 773-775
    CrossRef

  2. 2

    Alberto Giubilini, Francesca Minerva. . Partial-Birth and After-Birth Abortion. 2016:, 1-8.
    CrossRef

  3. 3

    Kasper Raus. (2016) The Extension of Belgium’s Euthanasia Law to Include Competent Minors. Journal of Bioethical Inquiry 13:2, 305-315
    CrossRef

  4. 4

    I.H. Zaal-Schuller, M.A. de Vos, F.V.P.M. Ewals, J.B. van Goudoever, D.L. Willems. (2016) End-of-life decision-making for children with severe developmental disabilities: The parental perspective. Research in Developmental Disabilities 49-50, 235-246
    CrossRef

  5. 5

    A. Busuttil. . Children: Infant Death Investigation. 2016:, 474-481.
    CrossRef

  6. 6

    , Rutger R. G. Knops, Leontien C. M. Kremer, A. A. Eduard Verhagen. (2015) Paediatric palliative care: recommendations for treatment of symptoms in the Netherlands. BMC Palliative Care 14
    CrossRef

  7. 7

    Katja ten Cate, Suzanne van de Vathorst, Bregje D Onwuteaka-Philipsen, Agnes van der Heide. (2015) End-of-life decisions for children under 1 year of age in the Netherlands: decreased frequency of administration of drugs to deliberately hasten death: Table 1. Journal of Medical Ethics 41, 795-798
    CrossRef

  8. 8

    Jan F. Koper, Arend F. Bos, Annie Janvier, A A Eduard Verhagen. (2015) Dutch neonatologists have adopted a more interventionist approach to neonatal care. Acta Paediatrica 104:10.1111/apa.2015.104.issue-9, 888-893
    CrossRef

  9. 9

    Rhiannon B. van Loenhout, Ivana M. M. van der Geest, Astrid M. Vrakking, Agnes van der Heide, Rob Pieters, Marry M. van den Heuvel-Eibrink. (2015) End-of-Life Decisions in Pediatric Cancer Patients. Journal of Palliative Medicine 18, 697-702
    CrossRef

  10. 10

    K ten Cate, S van de Vathorst. (2015) Dutch pediatricians’ views on the use of neuromuscular blockers for dying neonates: a qualitative study. Journal of Perinatology 35, 497-502
    CrossRef

  11. 11

    Willemien de Weerd, Donald van Tol, Marcel Albers, Pieter Sauer, Marian Verkerk. (2015) Suffering in children: opinions from parents and health-care professionals. European Journal of Pediatrics 174, 589-595
    CrossRef

  12. 12

    Geneviève Gridel, Ferdinando Cancelli, Petra Vayne-Bossert, Gilbert Zulian. (2015) Assistance au suicide : un choix personnel ou de société ?. Médecine Palliative : Soins de Support - Accompagnement - Éthique 14, 55-63
    CrossRef

  13. 13

    Lena Goldnagl, Wolfgang Freidl, Willibald J Stronegger. (2014) Attitudes among the general Austrian population towards neonatal euthanasia: a survey. BMC Medical Ethics 15:1
    CrossRef

  14. 14

    Felipe E. Vizcarrondo. (2014) Neonatal euthanasia: The Groningen Protocol. The Linacre Quarterly 81, 388-392
    CrossRef

  15. 15

    Catherine S. Yang, Daniela Kroshinksy, Brian M. Cummings. (2014) Neonatal Junctional Epidermolysis Bullosa: Treatment Conundrums and Ethical Decision Making. American Journal of Clinical Dermatology 15, 445-450
    CrossRef

  16. 16

    Udo Schuklenk. (2014) Physicians can justifiably euthanize certain severely impaired neonates. The Journal of Thoracic and Cardiovascular Surgery
    CrossRef

  17. 17

    A.A. Eduard Verhagen. (2014) Neonatal euthanasia: Lessons from the Groningen Protocol. Seminars in Fetal and Neonatal Medicine 19, 296-299
    CrossRef

  18. 18

    Peter Sidebotham, James Fraser, Peter Fleming, Martin Ward-Platt, Richard Hain. (2014) Patterns of child death in England and Wales. The Lancet 384, 904-914
    CrossRef

  19. 19

    Robert M. Sade. (2014) Can a physician ever justifiably euthanize a severely disabled neonate?. The Journal of Thoracic and Cardiovascular Surgery
    CrossRef

  20. 20

    Bernard Dan, Christine Fonteyne, Stéphan Clément de Cléty. (2014) Self-requested euthanasia for children in Belgium. The Lancet 383:9918, 671-672
    CrossRef

  21. 21

    Charlotte Haug. (2014) Dilemmaenes århundre. Tidsskrift for Den norske legeforening 134, 493-493
    CrossRef

  22. 22

    CarlosB Dabdoub, Ramiro Villavicencio, Germán Quevedo, CarlosF Dabdoub. (2014) How I Do It: Myelomeningocele in Bolivia. Surgical Neurology International 5, 39
    CrossRef

  23. 23

    Agustín Alfredo Silberberg, Juan Eduardo Gallo. (2013) Managing end-of-life decisions in critical infants: a survey of neonatologists in Cordoba, Argentina. Acta Paediatrica 102:10.1111/apa.2013.102.issue-10, e475-e477
    CrossRef

  24. 24

    Lainie Friedman Ross, Joel E. Frader. (2013) Newborns and Other Children: In Defense of Differential Attitudes and Treatment. The Journal of Pediatrics 162, 1096-1099
    CrossRef

  25. 25

    Vic Larcher. (2013) Ethical considerations in neonatal end-of-life care. Seminars in Fetal and Neonatal Medicine 18, 105-110
    CrossRef

  26. 26

    C. Gastmans, G. Naulaers, C. Vanhole, Y. Denier. (2013) From Birth to Death? A Personalist Approach to End-of-Life Care of Severely Ill Newborns. Christian Bioethics 19, 7-24
    CrossRef

  27. 27

    PJJ Sauer, JHHM Dorscheidt, AAE Verhagen, JH Hubben, . (2013) Medical practice and legal background of decisions for severely ill newborn infants: viewpoints from seven European countries. Acta Paediatrica 102:10.1111/apa.2013.102.issue-2, e57-e63
    CrossRef

  28. 28

    Concezio Di Rocco, Gianluca Trevisi, Luca Massimi. (2013) Myelomeningocele: An Overview. World Neurosurgery
    CrossRef

  29. 29

    Tracy K. Koogler. . Ethical issues in the care of the neurologically devastated infant. 2013:, 215-224.
    CrossRef

  30. 30

    Judith A. Baer. . An Introduction to Ironic Freedom. 2013:, 1-17.
    CrossRef

  31. 31

    Judith A. Baer. . Right to Die, Right to Live. 2013:, 19-36.
    CrossRef

  32. 32

    W.Y. Yuen, J.C. Duipmans, M.F. Jonkman. (2012) The needs of parents with children suffering from lethal epidermolysis bullosa. British Journal of Dermatology 167:10.1111/bjd.2012.167.issue-3, 613-618
    CrossRef

  33. 33

    W.Y. Yuen, J.C. Duipmans, B. Molenbuur, I. Herpertz, J.M. Mandema, M.F. Jonkman. (2012) Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa. British Journal of Dermatology 167:10.1111/bjd.2012.167.issue-2, 374-382
    CrossRef

  34. 34

    Mary L. Davenport, Jennifer Lahl, Evan C. Rosa. (2012) Right of Conscience for Health-Care Providers. The Linacre Quarterly 79, 169-191
    CrossRef

  35. 35

    M. J. Cherry. (2012) Conscience Clauses, the Refusal to Treat, and Civil Disobedience--Practicing Medicine as a Christian in a Hostile Secular Moral Space. Christian Bioethics 18, 1-14
    CrossRef

  36. 36

    John Wyatt, Bertie Leigh, Janet Rennie. . Ethical and legal aspects of neonatology. 2012:, 102-114.
    CrossRef

  37. 37

    Annie Janvier, William Meadow, Steven R. Leuthner, Bree Andrews, Joanne Lagatta, Arend Bos, Laura Lane, A. A. Eduard Verhagen. (2011) Whom are We Comforting? An Analysis of Comfort Medications Delivered to Dying Neonates. The Journal of Pediatrics 159, 206-210
    CrossRef

  38. 38

    M. J. Cherry. (2011) Sex, Abortion, and Infanticide: The Gulf between the Secular and the Divine. Christian Bioethics 17, 25-46
    CrossRef

  39. 39

    Robert E. Johnstone, Ronald L. Katz, Theodore H. Stanley. (2011) Homicides Using Muscle Relaxants, Opioids, and Anesthetic Drugs. Anesthesiology 114, 713-716
    CrossRef

  40. 40

    Dominic James Wilkinson. (2011) A Life Worth Giving? The Threshold for Permissible Withdrawal of Life Support From Disabled Newborn Infants. The American Journal of Bioethics 11, 20-32
    CrossRef

  41. 41

    Marie Hilliard. (2011) Utilitarianism Impacting Care of Those with Disabilities and Those at Life's End. The Linacre Quarterly 78, 59-71
    CrossRef

  42. 42

    Lars Materstvedt, Reidun Førde. (2011) Fra aktiv og passiv dødshjelp til eutanasi og behandlingsbegrensning. Tidsskrift for Den norske legeforening 131, 2138-2140
    CrossRef

  43. 43

    C. Dageville, P. Bétrémieux, F. Gold, U. Simeoni. (2011) The French Society of Neonatology’s Proposals for Neonatal End-of-Life Decision-Making. Neonatology 100, 206-214
    CrossRef

  44. 44

    Eric Kodish, Kathryn Weise. . Ethics in Pediatric Care. 2011:, 13-13.e17.
    CrossRef

  45. 45

    John D. Lantos. . The Interface of Ethics and Palliative Care. 2011:, 119-122.
    CrossRef

  46. 46

    N. Scolding. (2011) Right to die?. Brain 134, 318-321
    CrossRef

  47. 47

    Ola Didrik Saugstad. (2011) A Time to Be Born and a Time to Die: Ethical Challenges in the Neonatal Intensive Care Unit. Neonatology 100, 215-216
    CrossRef

  48. 48

    Cameron H Swinton, John D Lantos. (2010) Current empirical research in neonatal bioethics. Acta Paediatrica 99, 1773-1781
    CrossRef

  49. 49

    Nathalie Teisseyre, Charles Vanraet, Paul C. Sorum, Etienne Mullet. (2010) The Acceptabilityamong Lay Persons and Health Professionals of Actively Ending the Lives of Damaged Newborns. Monash Bioethics Review 29, 41-64
    CrossRef

  50. 50

    J.W. Dudenhausen. (2010) Indikationen zur Schnittentbindung an der Grenze der Lebensfähigkeit. Der Gynäkologe 43, 472-474
    CrossRef

  51. 51

    B. Arabin, L. Hellmeyer. (2010) Unterschiede der Behandlungsgrenzen in Europa. Der Gynäkologe 43, 483-494
    CrossRef

  52. 52

    Lars Grue. (2010) Eugenics and euthanasia – then and now. Scandinavian Journal of Disability Research 12, 33-45
    CrossRef

  53. 53

    Patricia A. Aronin, Timothy M. George. (2010) Commentary on ‘Quality of Life and Myelomeningocele: An Ethical and Evidence-Based Analysis of the Groningen Protocol’ by Sean Barry, Pediatr Neurosurg 2010;46:409–414. Pediatric Neurosurgery 46, 415-416
    CrossRef

  54. 54

    Sara Naghib, Cynthia Starre, Saskia J. Gischler, Koen F. M. Joosten, Dick Tibboel. (2010) Mortality in very long-stay pediatric intensive care unit patients and incidence of withdrawal of treatment. Intensive Care Medicine 36, 131-136
    CrossRef

  55. 55

    J.M. Fanaroff. (2010) Analgesics, sedatives and neuromuscular blockers as part of end-of-life decisions in Dutch NICUs. Yearbook of Neonatal and Perinatal Medicine 2010, 267-269
    CrossRef

  56. 56

    Gregory S. Liptak, Ahmad El Samra. (2010) Optimizing health care for children with spina bifida. Developmental Disabilities Research Reviews 16:10.1002/ddrr.v16:1, 66-75
    CrossRef

  57. 57

    Robin M. Bowman, David G. McLone. (2010) Neurosurgical management of spina bifida: Research issues. Developmental Disabilities Research Reviews 16:10.1002/ddrr.v16:1, 82-87
    CrossRef

  58. 58

    Sean Barry. (2010) Quality of Life and Myelomeningocele: An Ethical and Evidence-Based Analysis of the Groningen Protocol. Pediatric Neurosurgery 46, 409-414
    CrossRef

  59. 59

    A.A. Eduard Verhagen, Annie Janvier, Steven R. Leuthner, B. Andrews, J. Lagatta, Arend F. Bos, William Meadow. (2010) Categorizing Neonatal Deaths: A Cross-Cultural Study in the United States, Canada, and The Netherlands. The Journal of Pediatrics 156, 33-37
    CrossRef

  60. 60

    Alexander A. Kon. (2009) Neonatal Euthanasia. Seminars in Perinatology 33, 377-383
    CrossRef

  61. 61

    Jacob M. Appel. (2009) Neonatal Euthanasia: Why Require Parental Consent?. Journal of Bioethical Inquiry 6, 477-482
    CrossRef

  62. 62

    Emanuela Turillazzi, Vittorio Fineschi. (2009) How old are you? Newborn gestational age discriminates neonatal resuscitation practices in the Italian debate. BMC Medical Ethics 10:1
    CrossRef

  63. 63

    Marina Cuttini, Veronica Casotto, Umberto de Vonderweid, Micheline Garel, Louis A. Kollée, Rodolfo Saracci. (2009) Neonatal end-of-life decisions and bioethical perspectives. Early Human Development 85, S21-S25
    CrossRef

  64. 64

    Marie-Aurélie Bruno, Caroline Schnakers, François Damas, Frédéric Pellas, Isabelle Lutte, Jan Bernheim, Steve Majerus, Gustave Moonen, Serge Goldman, Steven Laureys. (2009) Locked-In Syndrome in Children: Report of Five Cases and Review of the Literature. Pediatric Neurology 41, 237-246
    CrossRef

  65. 65

    S. van der Vossen, L. R. Pistorius, E. J. H. Mulder, M. Platenkamp, P. Stoutenbeek, G. H. A. Visser, R. H. J. M. Gooskens. (2009) Role of prenatal ultrasound in predicting survival and mental and motor functioning in children with spina bifida. Ultrasound in Obstetrics and Gynecology 34:10.1002/uog.v34:3, 253-258
    CrossRef

  66. 66

    Nathan Gamester, Bart Van den Eynden. (2009) The Relationship between Palliative Care and Legalized Euthanasia in Belgium. Journal of Palliative Medicine 12, 589-591
    CrossRef

  67. 67

    Robin M. Bowman, Vanda Boshnjaku, David G. McLone. (2009) The changing incidence of myelomeningocele and its impact on pediatric neurosurgery: a review from the Children’s Memorial Hospital. Child's Nervous System 25, 801-806
    CrossRef

  68. 68

    Frank A. Chervenak, Laurence B. McCullough, Birgit Arabin. (2009) The Groningen Protocol: Is it necessary? Is it scientific? Is it ethical?. Journal of Perinatal Medicine 37, 199-205
    CrossRef

  69. 69

    Stephen S. Hanson. (2009) Still on the Same Slope: Groningen Breaks No New Ethical Ground. The American Journal of Bioethics 9, 67-68
    CrossRef

  70. 70

    Sandra Woien. (2008) Life, Death, and Harm: Staying Within the Boundaries of Nonmaleficence. The American Journal of Bioethics 8, 31-32
    CrossRef

  71. 71

    Martine C. de Vries, A. A. Eduard Verhagen. (2008) A Case Against Something That Is Not the Case: The Groningen Protocol and the Moral Principle of Non-Maleficence. The American Journal of Bioethics 8, 29-31
    CrossRef

  72. 72

    Alexander A. Kon. (2008) We Cannot Accurately Predict the Extent of an Infant's Future Suffering: The Groningen Protocol is too Dangerous to Support. The American Journal of Bioethics 8, 27-29
    CrossRef

  73. 73

    Alan Jotkowitz, S. Glick, B. Gesundheit. (2008) A Case Against Justified Non-Voluntary Active Euthanasia (The Groningen Protocol). The American Journal of Bioethics 8, 23-26
    CrossRef

  74. 74

    Bertha Manninen. (2008) Revisiting Justified Nonvoluntary Euthanasia. The American Journal of Bioethics 8, 33-35
    CrossRef

  75. 75

    Jean Bethke Elshtain. (2008) Why science cannot stand alone. Theoretical Medicine and Bioethics 29, 161-169
    CrossRef

  76. 76

    J Gadzinowski. (2008) Neonatal mortality: the chance for improvement. Journal of Perinatology 28, 317-318
    CrossRef

  77. 77

    Eric Kodish. (2008) Paediatric ethics: a repudiation of the Groningen protocol. The Lancet 371, 892-893
    CrossRef

  78. 78

    Andrew B. Pinter. (2008) End-of-life decision before and after birth: changing ethical considerations. Journal of Pediatric Surgery 43, 430-436
    CrossRef

  79. 79

    FRANK A CHERVENAK, LAURENCE B McCULLOUGH. (2008) THE ETHICS OF FETOCIDE. Fetal and Maternal Medicine Review 18:04
    CrossRef

  80. 80

    Kenneth Kipnis. (2007) Harm and Uncertainty In Newborn Intensive Care. Theoretical Medicine and Bioethics 28, 393-412
    CrossRef

  81. 81

    Alexander A. Kon. (2007) Neonatal Euthanasia Is Unsupportable: The Groningen Protocol Should Be Abandoned. Theoretical Medicine and Bioethics 28, 453-463
    CrossRef

  82. 82

    Dave McLone. (2007) Deliberate termination of life of newborns with spina bifida. Child's Nervous System 24, 33-34
    CrossRef

  83. 83

    T. H. Rob Jong. (2007) Deliberate termination of life of newborns with spina bifida, a critical reappraisal. Child's Nervous System 24, 13-28
    CrossRef

  84. 84

    L. d’Agincourt-Canning, P. Thiessen, D. D. Cochrane. (2007) Deliberate termination of life of newborns with spina bifida. Child's Nervous System 24, 29-31
    CrossRef

  85. 85

    Notes. 2007:, 259-298.
    CrossRef

  86. 86

    Frank A Chervenak, Laurence B McCullough, Birgit Arabin. (2007) Ethical challenges of neonatal euthanasia. Expert Review of Obstetrics & Gynecology 2, 707-709
    CrossRef

  87. 87

    W. L. Lanier, K. H. Berge. (2007) Physician Involvement in Capital Punishment: Simplifying a Complex Calculus. Mayo Clinic Proceedings 82, 1043-1046
    CrossRef

  88. 88

    John Wyatt. (2007) End-of-life decisions, quality of life and the newborn. Acta Paediatrica 96, 790-791
    CrossRef

  89. 89

    Astrid M. Vrakking, Agnes Van Der Heide, Veerle Provoost, Johan Bilsen, Gerrit Van Der Wal, Luc Deliens. (2007) End-of-life decision making in neonates and infants: comparison of the Netherlands and Belgium (Flanders). Acta Paediatrica 96, 820-824
    CrossRef

  90. 90

    Alan Jotkowitz. (2007) Is There Life Not Worthy of Living?. The American Journal of Bioethics 7, 62-63
    CrossRef

  91. 91

    J.A. Stockman. (2007) Trends in Suicide Ideation, Plans, Gestures, and Attempts in the United States, 1990-1992 to 2001-2003. Yearbook of Pediatrics 2007, 368
    CrossRef

  92. 92

    Florence J. Zuuren, Eeke Manen. (2006) Moral dilemmas in neonatology as experienced by health care practitioners: A qualitative approach. Medicine, Health Care and Philosophy 9, 339-347
    CrossRef

  93. 93

    SP Verloove-Vanhorick. (2006) Management of the neonate at the limits of viability: the Dutch viewpoint. BJOG: An International Journal of Obstetrics & Gynaecology 113, 13-16
    CrossRef

  94. 94

    Robert Truog. (2006) Reply to the comment by Dr. Solsona et al.. Intensive Care Medicine 32, 1662-1662
    CrossRef

  95. 95

    Jordan Hochman. (2006) The Difficulty of Tending to the Suffering Terminal Patient: An Exploration of Euthanasia and Physician-Assisted Suicide. The Laryngoscope 116, 1526-1527
    CrossRef

  96. 96

    Isabell B. Purdy. (2006) Embracing Bioethics in Neonatal Intensive Care, Part I: Evolving Toward Neonatal Evidence-Based Ethics. Neonatal Network: The Journal of Neonatal Nursing 25, 33-42
    CrossRef

  97. 97

    (2005) Futility in Medical Decisions: The Word and the Concept. HEC Forum 17, 308-318
    CrossRef

  98. 98

    Frans J. Walther. (2005) Withholding treatment, withdrawing treatment, and palliative care in the neonatal intensive care unit. Early Human Development 81, 965-972
    CrossRef

  99. 99

    Ola Saugstad. (2005) When newborn infants are bound to die. Acta Paediatrica 94, 1535-1537
    CrossRef

  100. 100

    (2005) Euthanasia in Severely Ill Newborns. New England Journal of Medicine 352:22, 2353-2355
    Free Full Text

Letters

Trends

Most Viewed (Last Week)